Cambridge Nutritional Sciences PLC (CNSL)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

1.80p

Buy

2.10p

arrow-up0.00p (+0.00%)

Prices updated at 12 Dec 2025, 15:24 GMT

Prices minimum 15 mins delay

Prices in GBX

Omega Diagnostics Group PLC provides in-vitro diagnostics (IVD) products for use in hospitals, blood banks, clinics and laboratories and specializes in the areas of allergy and autoimmune, food intolerance and infectious diseases.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

Ms. Carolyn Ann Rand

CEO

Mr. James Cooper

Most recent earnings

31 Mar 2025

Fiscal year end

31 Mar 2025

Employees

84

Head office

One Fleet Place

London

United Kingdom

EC4M 7WS

-

odl@omegadiagnostics.co.uk

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Ms. Carolyn Ann Rand Non-Executive Director, Chairman	-
Mr. Jeremy Howard Millard Non-Executive Director	-
Mr. Ajay Patel Executive Director, Chief Financial Officer	-
Mr. James Cooper Executive Director, Chief Executive Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Unicorn Asset Management Ltd	3,700,000
Unicorn AIM VCT Series 3 ORD	3,700,000

Director dealings

Date chevron-l-regular chevron-r-regular	Action
18 Nov 2025	Purchase
18 Nov 2025	Purchase
18 Nov 2025	Purchase
05 Feb 2025	Purchase
29 Jan 2025	Purchase

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.